Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2003
03/06/2003US20030045695 Ribozyme for detecting gene sequence
03/06/2003US20030045693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045690 Having a mean diameter of 200-2000 nm, obtained by solidification from a mixture comprising fibrinogen, thrombin and Factor XIII in an water in oil emulsion
03/06/2003US20030045686 Mutein polypeptide for use in the treatment of hypoxia and ischemic related tissue damages
03/06/2003US20030045684 Polypeptide for use in humans therapeutics and diagnostics
03/06/2003US20030045682 Antibodies immunospecific for STEAP1
03/06/2003US20030045494 Synthetic oligonucleotides complementary to nucleic acids encoding epidermal growth factor
03/06/2003US20030045479 Novel N-formyl hydroxylamine compounds, compositions and methods of use
03/06/2003US20030045470 Methods and compositions for modulating gluconeogenesis using PGC-1
03/06/2003US20030045466 Calcium binding protein
03/06/2003US20030045463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045462 Also vectors and host cells comprising those nucleic acid sequences, chimeric molecules of these polypeptides fused to heterologous polypeptide sequences, antibodies which bind to these polypeptides
03/06/2003US20030045459 67 Human secreted proteins
03/06/2003US20030045451 Determining or predicting response to cancer therapy in an individual using differential image analysis of immunohistochemically stained tumor samples.
03/06/2003US20030044978 Expanded and genetically modified populations of human hematopoietic stem cells
03/06/2003US20030044977 Cell culture for use in treatment of parkinson's disease
03/06/2003US20030044976 De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
03/06/2003US20030044974 Method for collecting cells in M phase or G1 phase and method for nuclear transplantation using the cells
03/06/2003US20030044973 Mammalian adrenocorticotropic hormone receptors and uses
03/06/2003US20030044962 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
03/06/2003US20030044958 Nucleotide sequences coding polypeptide for use in monitoring and treating inflammatory disorders
03/06/2003US20030044950 Phosphodiesterase 10
03/06/2003US20030044945 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044937 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and cancer
03/06/2003US20030044912 KCNQ potassium channels and methods of modulating same
03/06/2003US20030044910 Nucleotide sequences coding membrane protein for use in the treatment and prevention of viral and tumor diseases
03/06/2003US20030044909 Modulator of melatonin binding for use in the treatment of circadian rythm disorders
03/06/2003US20030044907 Nucleotide sequences coding polypeptide for use in the treatment and prevention of infections, gastrointestinal and inflammatory disorders
03/06/2003US20030044905 Nucleic acids, proteins, and antibodies
03/06/2003US20030044904 Nucleotide sequences coding polypeptides for use in the treatment of blood, tumor and urogenital disorders
03/06/2003US20030044902 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of skin and tumor disorders
03/06/2003US20030044901 Polypeptide for use in animal models associated with human therapeutics
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof
03/06/2003US20030044890 Nucleotide sequences coding polypeptide for use in the treatment of Alzheimer's disease and brain disorders
03/06/2003US20030044888 Polypeptide for use in the treatment of addison's disease
03/06/2003US20030044887 Neurogenin
03/06/2003US20030044883 Method of screening candidate compounds for susceptibility to biliary excretion
03/06/2003US20030044851 Secreted protein HCEJQ69
03/06/2003US20030044844 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044841 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044839 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044831 Antibody for use in the generation and protection of preferential nucleotide sequences
03/06/2003US20030044828 Progressive elevated gene-3 (PEG-3) induces aggressive cancer phenotype and regulates angiogenesis
03/06/2003US20030044806 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders
03/06/2003US20030044792 Methods and materials relataing to novel stem cell growth factor-like polypeptides and polynucleotides
03/06/2003US20030044783 Human genes and gene expression products
03/06/2003US20030044765 Use of cytokines and mitogens to inhibit pathological immune responses
03/06/2003US20030044468 Shaping polymeric precursors by inducing thermal gelation of an aqueous solution thereof and then curing said precursors by crosslinking reactive groups; biomedical uses include drug delivery, microencapsulation, implantation
03/06/2003US20030044423 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype
03/06/2003US20030044403 Anti-infective therapy
03/06/2003US20030044396 Tissue engineering; generating thymus tissue
03/06/2003US20030044395 Artificial tissue, skin
03/06/2003US20030044394 Activating lymphocytes
03/06/2003US20030044393 Method for increasing tumor cell immunogenicity using heat shock protein
03/06/2003US20030044391 Preparation and xenotransplantation of porcine islets
03/06/2003US20030044390 Applying stresses to blood sampling
03/06/2003US20030044387 Liver cancer therapy
03/06/2003US20030044386 Genetic engineering; nucleic acid coding cytokines
03/06/2003US20030043176 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030041800 Application apparatus of 3-dimensional kilonostat and growing method using the same
03/06/2003US20030041386 Graft prosthesis, materials and methods
03/06/2003CA2496180A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003CA2458972A1 Regulation of cytotrophoblast cell differentiation and cell migration
03/06/2003CA2458866A1 Compositions and methods of treating diabetes
03/06/2003CA2458627A1 Human cdr-grafted antibody and antibody fragment thereof
03/06/2003CA2458575A1 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
03/06/2003CA2458574A1 Reagents and methods for smooth muscle therapies
03/06/2003CA2458559A1 Gene of novel corynebacterium diphtheriae antigen
03/06/2003CA2458445A1 Extracellular messengers
03/06/2003CA2458381A1 Transmembrane protein differentially expressed in cancer
03/06/2003CA2458362A1 Isolation of inner cell mass for the establishment of human embryonic stem cell (hesc) lines
03/06/2003CA2458261A1 Differentiation of neural stem cells and therapeutic use thereof
03/06/2003CA2458228A1 Molecular interaction sites of 16s ribosomal rna and methods of modulating the same
03/06/2003CA2458226A1 Improved nitroreductase enzymes
03/06/2003CA2458224A1 A universal light-switchable gene promoter system
03/06/2003CA2457915A1 Novel human proteases and polynucleotides encoding the same
03/06/2003CA2457879A1 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003CA2457807A1 Ashbya gossypii enzymes
03/06/2003CA2457779A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003CA2457477A1 Self-processing plants and plant parts
03/06/2003CA2456828A1 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003CA2421442A1 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
03/05/2003EP1288301A1 Plant-derived resistance gene
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288298A2 TRNA synthetase from Staphylococcus aureus
03/05/2003EP1288293A1 Human neural stem cells originated from human amniotic mesenchymal cell layer
03/05/2003EP1288292A1 Long peptides of 22-40 amino acid residues that induce and/or enhance antigen specific immune responses.
03/05/2003EP1288291A1 Method of amplifying natural killer t cells
03/05/2003EP1287830A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
03/05/2003EP1287362A2 Compositions and methods for modulating tumor specific expression
03/05/2003EP1287357A2 Artificial antigen presenting cells and methods of use thereof
03/05/2003EP1287351A2 Lipid bilayer array methods and devices
03/05/2003EP1287161A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
03/05/2003EP1287147A2 Immunotoxin fusion proteins and means for expression thereof
03/05/2003EP1287146A2 Cold sensitive mutant dna polymerases
03/05/2003EP1287144A2 Bacterial insecticidal proteins
03/05/2003EP1287142A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
03/05/2003EP1287141A2 Extracellular messengers
1 ... 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 ... 1827